Text Size
35 studies found for:    Open Studies | "Alopecia"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Alopecia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
Intervention:
2 Recruiting Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
Conditions: Alopecia Areata;   Alopecia;   Balding
Interventions: Procedure: Hair transplantation;   Procedure: Hypodermic needle irritation
3 Unknown † Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Condition: Alopecia
Intervention: Drug: Clobetasol Propionate 0.05% Emollient Foam
4 Recruiting Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
Condition: Alopecia Areata
Interventions: Device: 308-nm excimer laser to alopecia patch;   Device: Liquid light guide tip on laser
5 Not yet recruiting A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia
Condition: Alopecia
Intervention: Drug: Dutasteride 0.5 mg
6 Unknown † Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
7 Unknown † Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
8 Unknown † Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata
Condition: Alopecia Areata
Interventions: Device: Subcutaneous injection luer syringe;   Device: DERMOJET (a syringe without a needle)
9 Unknown † Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Condition: Alopecia
Interventions: Drug: 7% (w/v) Tempol alcohol-based gel (MTS-01);   Drug: alcohol-based gel
10 Recruiting Stem Cell Educator Therapy in Alopecia Areata
Condition: Alopecia Areata
Intervention: Device: Stem Cell Educator
11 Recruiting Excimer Light for Alopecia Areata
Condition: Alopecia Areata
Intervention: Procedure: UVB excimer light
12 Not yet recruiting Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Radiation: ultraviolet A (UVA);   Drug: Triamcinolone Acetonide
13 Recruiting Vytorin in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: vytorin
14 Recruiting The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
15 Unknown † Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Intervention: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
16 Recruiting AVODART® Alopecia Post-marketing Surveillance (PMS)
Condition: Alopecia
Intervention: Drug: Dutasteride
17 Recruiting Alopecia Areata Registry and Immunogenetic Mechanisms
Condition: Alopecia Areata
Intervention: Behavioral: questionnaires
18 Recruiting Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10);   Device: Restylane
19 Recruiting Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Interleukin-2
20 Recruiting The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
Condition: Female Pattern Alopecia
Interventions: Drug: 15 mg Chelate zinc supplement;   Drug: Placebo drug supplement
To Top

Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results
† Indicates status has not been verified in more than two years